EGFR-AS1 Promotes Nonsmall Cell Lung Cancer (NSCLC) Progression via Downregulating the miR-524-5p/DRAM1 Axis and Inhibiting Autophagic Lysosomal Degradation

Figure 3

miR-524-5p inhibition promoted NSCLC cell progression. (a) The effect of si-EGFR-AS1 and miR-524-5p inhibitors on the miR-524-5p expression level. One-way ANOVA was applied. (b) The CCK-8 assay determined the effect of inhibiting miR-524-5p and EGFR-AS1 on NSCLC cell viability. Two-way ANOVA was applied. (c) The effect of inhibiting miR-524-5p and EGFR-AS1 on NSCLC cell invasion. One-way ANOVA was applied. The data are represented as mean ± S.D.  < 0.05,  < 0.01, and  < 0.001.

(a)

(b)

(c)